Sodium oxybate-induced sleep driving and sleep-related eating disorder
- PMID: 21677903
- PMCID: PMC3113972
- DOI: 10.5664/JCSM.1082
Sodium oxybate-induced sleep driving and sleep-related eating disorder
Abstract
Hypnosedative-induced complex behaviors have gained increased attention in recent years as a potential complication of benzodiazepines and benzodiazepine-receptor agonist use. Sodium oxybate (SO), the sodium salt of γ-hydroxybutyrate, an inhibitory neurotransmitter, has been associated with dose-dependent rates of somnambulism; however, there is limited information about complex motor behaviors with SO. We describe a patient with narcolepsy-cataplexy who experienced one episode of sleep-driving and at least two sleep-related eating episodes with therapeutic doses of SO.
Keywords: Sodium oxybate; narcolepsy; parasomnia; sleep driving; sleep related eating disorder.
References
-
- Jazz Pharmaceuticals, Inc. Xyrem (sodium oxybate): prescribing information [online] [Accessed 2010 Aug 20]. Available from URL: http://www.xyrem.com/xyrem-pi.pdf.
-
- Mamelak M, Black J, Montplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep. 2004;27:1327–34. - PubMed
-
- Dolder CR, Nelson MH. Hypnosedative-induced complex behaviours: incidence, mechanisms and management. CNS Drugs. 2008;22:1021–36. - PubMed
-
- Lam SP, Fong SY, Ho CK, Wing YK. Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatry. 2008;69:1374–82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
